CF
Publicaties op Oncologisch.com
Belantamab mafodotin plus bortezomib and dexamethasone in patiënten met relapsed or refractory multiple myeloma (DREA...
Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with De Novo Acute Myeloid Leukemi...
Belantamab mafodotin plus bortezomib-dexamethason bij myeloom: DREAMM-7 fase III